Ieramilimab(Synonyms: LAG525; IMP701)

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

Ieramilimab (Synonyms: LAG525; IMP701)

Ieramilimab (LAG525; IMP701) 是一种人源化 IgG4 单克隆抗体,可与 LAG-3 结合,从而抑制 LAG-3 与 MHC-II 分子的相互作用。

Ieramilimab(Synonyms: LAG525;  IMP701)

Ieramilimab Chemical Structure

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

Ieramilimab (LAG525; IMP701) is a humanized IgG4 monoclonal antibody that binds to LAG-3, resulting in inhibition of LAG-3 interaction with MHC-II molecules[1].

中文名称

埃拉利单抗

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Patrick Schöffski, et al. Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies. J Immunother Cancer. 2022 Feb;10(2):e003776.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务